Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor

Cancer Science

Volumn 101, Issue 7, 2010, Pages 1653-1660

  Liu, Lili ^a   Sun, Li ^b   Zhao, Pengtao ^c   Yao, Liping ^b   Jin, Haifeng ^b   Liang, Shuhui ^b   Wang, Yanxia ^c   Zhang, Dexin ^b   Pang, Yanglin ^b   Shi, Yongquan ^b   Chai, Na ^b   Zhang, Hongbo ^b   Zhang, Helong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

67 KDA LAMININ RECEPTOR; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; LAMININ RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RNA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH CANCER; TIME; UPREGULATION; WESTERN BLOTTING;

ACTINS; BASE SEQUENCE; CELL ADHESION; CELL HYPOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTORS, LAMININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77954645380     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01592.x     Document Type: Article

References (26)

1. Brahimi-Horn MC, Chiche J, Pouysségur J. Hypoxia and cancer. J Mol Med 2007, 85:1301-7.
2. Chang Q, Qin R, Huang T, Gao J, Feng Y. Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 2006, 32:297-305.
3. Yoo YG, Kong G, Lee MO. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J 2006, 22:1231-41.
4. Horwitz VG, Davidson B, Reich R. Laminin-induced signaling in tumor cells: the role of the Mr 67,000 laminin receptor. Cancer Res 2004, 64:3572-9.
5. Selleri C, Ragno P, Ricci P. The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood 2006, 108:2476-84.
6. Me′nard S, Castronovo V, Tagliabue E, Sobel ME. New insights into the metastasis associated 67 kD laminin receptor. J Cell Biochem 1997, 67:155-65.
7. Liu LL, Sun L, Zhang HB. hypoxia- Mediated Up-Regulation of MGr1-Ag/37LRP in gastric cancers occurs via Hypoxia- inducible-Factor 1-Dependent Mechanism and contributes to Drug Resistance. Int J Cancer 2009, 124:1707-15.
8. Pan Y, Bi F, Liu N. Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 2004, 315:686-91.
9. Hu S, Guo X, Xie H. Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential. Biochem Biophys Res Commun 2006, 341:964-72.
10. Liu N, Bi F, Pan Y. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 2004, 15:6239-47.
11. Mazzieri R, Masiero L, Zanetta L. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-boundreactants. EMBO J 1997, 16:2319-32.
12. Jin HF, Pan YL, He LJ. p75 Neurotrophin Receptor Inhibits Invasion and Metastasis of Gastric Cancer. Mol Cancer Res 2007, 5:423-33.
13. Liu L, Ning X, Sun L. Hypoxia-inducible factor-1α contributes to Hypoxia-induced Chemoresistance in Gastric Cancer. Cancer Sci 2008, 99(1):121-8.
14. Chen FX, Qian YR, Duan YH. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro. Brain Res Bull 2009, 14:402-8.
15. Li D, Chen J, Gao Z, Li X, Yan X, Xiong Y. Wang S. 67-kDa laminin receptor in human bile duct carcinoma. Eur Surg Res 2009, 42:168-73.
16. Morais Freitas V, Nogueira da Gama de Souza L, Cyreno Oliveira E, Furuse C, Cavalcanti de Araújo V, Gastaldoni Jaeger R. Malignancy-related 67kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression. Oral Oncol 2007, 43:987-98.
17. Molino A, Pedersini R, Micciolo R. Prognostic significance of laminin, laminin receptor, and bone marrow micrometastases in breast cancer patients: are these markers of aggressive behavior and metastatic potential? Appl Immunohistochem Mol Morphol 2003, 11:311-8.
18. Diggle CP, Cruickshank S, Olsburgh JD. Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor. Am J Pathol 2003, 163:493-504.
19. Ohno Y, Izumi M, Tachibana M. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines. Oncol Rep 2008, 20:501-9.
20. Zuber C, Knackmuss S, Zemora G. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-KDa/67-KDa laminin receptor. J Mol Bio 2008, 378:530-9.
21. Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci 2003, 94:43-9.
22. Mahabeleshwar GH, Das R, Kundum GC. Tyrosine Kinase, p56lck-induced Cell Motility, and Urokinase-type Plasminogen Activator Secretion Involve Activation of Epidermal Growth Factor Receptor/Extracellular Signal Regulated Kinase Pathways. J Biological Chemistry 2004, 279:9733-42.
23. Gebarowska D, Stitt AW, Gardiner TA, Harriott P, Greer B, Nelson J. Synthetic Peptides Interacting with the 67-kd Laminin Receptor Can Reduce Retinal Ischemia and Inhibit Hypoxia-Induced Retinal Neovascularization. Am J Pathology 2002, 160:307-13.
24. Comerford KM, Cummins EP, Taylor CT. c-Jun NH2-Terminal Kinase Activation Contributes to Hypoxia-Inducible Factor1α-Dependent P-Glycoprotein Expression in Hypoxia. Cancer Res 2004, 64:9057-61.
25. Lester RD, Jo M, Campana WM, Gonias SL. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 2005, 25:39273-7.
26. Liu LL, Zhang HB, Sun L. ERK/MAPK activation contributes to Hypoxia-Inducible Factor-1α-Dependent MGr1-Ag/37LRP expression and increased resistance to Apoptosis. Int J Cancer 2009, [Epub ahead of print]